Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Cipla enters exclusive licensing agreement with SBP Group for HER2 bispecific ADC Rolditamig Deuderuxtecan (TQB2102) in India, South Africa and 5 other emerging markets. Cipla will handle local clinic